Trials / Conditions / NFE2L2 Gene Mutation
NFE2L2 Gene Mutation
3 registered clinical trials studyying NFE2L2 Gene Mutation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cance NCT05275673 | Faeth Therapeutics | Phase 2 |
| Terminated | NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial NCT04698681 | Calithera Biosciences, Inc | — |
| Terminated | KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, NCT04265534 | Calithera Biosciences, Inc | Phase 2 |